Zydus has received the Establishment Inspection Report (EIR) from the USFDA for the inspection conducted at its manufacturing facility located at Pharmez, Ahmedabad from March 20 to 24, 2023, the company announced on Mo0nday through an exchange filing.
The inspection has been classified as Voluntary Action Indicated (VAI). The EIR report indicates that the inspection is closed.
Zydus Shares
The shares of Zydus on Monday at 11:18 am IST were at Rs 590.85, up by 1.34 percent.
Maharashtra Politics: New Political Front Emerges In Mira-Bhayandar Municipal Corporation As Shiv Sena (Shinde) & Congress Join Hands
Adani Ports To Launch ₹16,000 Crore Vizhinjam Phase 2 Development, Adding 4.1 Mn TEUs Capacity
'Reprimanded For Coming To Hostel Drunk': Second-Year B-Tech Student Jumps To Death In Greater Noida
East Coast Railway Hits ₹23,000 Crore Freight Earnings 27 Days Early In FY26, Tops Indian Railways In Loading
